Abelardo Caballero
Overview
Explore the profile of Abelardo Caballero including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
44
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Torio A, Cabo-Zabala L, Rodriguez-Nicolas A, Caballero A
HLA
. 2024 Jan;
103(1):e15339.
PMID: 38212252
Identification of the novel HLA-C*05:279 allele that differs from C*05:01:01:11 by two nucleotide substitutions.
2.
Torio A, Rodriguez-Nicolas A, Cabo-Zabala L, Caballero A
HLA
. 2023 Sep;
103(1):e15242.
PMID: 37776303
A novel HLA-A*33 allele, officially designated HLA-A*33:237, was identified by next-generation sequencing.
3.
Hernandez D, Caballero A
Nefrologia (Engl Ed)
. 2023 Aug;
43(3):281-292.
PMID: 37635014
Although the results of kidney transplantation (KT) have improved substantially in recent years, a chronic and inexorable loss of grafts mainly due to the death of the patient and chronic...
4.
Vazquez-Sanchez T, Sanchez-Nino M, Ruiz-Esteban P, Lopez V, Leon M, Caballero A, et al.
J Clin Med
. 2023 Jul;
12(13).
PMID: 37445521
We investigated the evolution of serum klotho (s-Kl) and FGF-23 during the first two years post-kidney transplantation (KT), considering the cold ischemia time (CIT), glomerular filtration rate (GFR) and graft...
5.
Hernandez D, Vazquez-Sanchez T, Sola E, Lopez V, Ruiz-Esteban P, Caballero A, et al.
BMC Nephrol
. 2022 Nov;
23(1):357.
PMID: 36344929
Background: Subclinical inflammation, including borderline lesions (BL), is very common (30-40%) after kidney transplantation (KT), even in low immunological risk patients, and can lead to interstitial fibrosis/tubular atrophy (IFTA) and...
6.
Caballero A, Vazquez-Sanchez T, Ruiz-Esteban P, Leon M, Alonso-Titos J, Lopez V, et al.
J Clin Med
. 2021 Nov;
10(21).
PMID: 34768571
We determined the association between CD14++CD16+ monocytes and subclinical infiltrates that do not reach the histological threshold for rejection (≥Banff IA). We studied low-immunological-risk kidney-transplant recipients in a clinical trial...
7.
Hernandez D, Alonso-Titos J, Vazquez T, Leon M, Caballero A, Cobo M, et al.
J Clin Med
. 2021 Jun;
10(9).
PMID: 34067039
The impact of corticosteroid withdrawal on medium-term graft histological changes in kidney transplant (KT) recipients under standard immunosuppression is uncertain. As part of an open-label, multicenter, prospective, phase IV, 24-month...
8.
Hernandez D, Vazquez T, Alonso-Titos J, Leon M, Caballero A, Cobo M, et al.
J Clin Med
. 2021 May;
10(9).
PMID: 33947168
The impact of human leukocyte antigen (HLA)-mismatching on the early appearance of subclinical inflammation (SCI) in low-immunological-risk kidney transplant (KT) recipients is undetermined. We aimed to assess whether HLA-mismatching (A-B-C-DR-DQ)...
9.
Cabrera C, Mendez-Lopez I, Caballero A
Scand J Gastroenterol
. 2018 Jan;
53(3):266-272.
PMID: 29361871
Objectives: To date, the greatest genetic risk factor known for celiac disease (CD) is the presence of HLA-DQ2 heterodimers, specifically DQ2.5 in state of homozygosis or heterozygosis. DQ2.2 variants are...
10.
Caballero A, Palma E, Ruiz-Esteban P, Sola E, Lopez V, Fuentes L, et al.
Ann Transplant
. 2017 Jan;
22:35-41.
PMID: 28115732
BACKGROUND Studies of liver and heart transplant patients have shown a gradual reconstruction of the CD8 KIR2D+ T cell subpopulations, measured in peripheral blood (PB), associated with better graft acceptance....